Ingalls & Snyder »

Heron Therapeutics shares owned by Ingalls & Snyder

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Ingalls & Snyder from 13F filings

Historical chart of Ingalls & Snyder investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Ingalls & Snyder

Quarter filed Position value Share count Share price at filing
2023-12-31 $19k 11k 1.66
2023-09-30 $12k 11k 1.05
2023-06-30 $13k 11k 1.14
2023-03-31 $17k 11k 1.49
2022-12-31 $29k 11k 2.54
2022-09-30 $60k 14k 4.25
2022-06-30 $39k 14k 2.76